Company Overview and News

0
Huhtamaki PPL Limited - Updates

2018-07-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

0
Huhtamaki PPL Limited - Trading Window

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

0
Company news: Huhtamaki PPL

2018-06-04 thehindubusinessline
Huhtamaki PPL has informed the exchanges that there was a fire accident at its factory at TTC Industrial Estate, Processing Zone, Mahape, Navi Mumbai, on Saturday. The fire, which broke out in an adjoining factory, spread to its factory, but was brought under control by the Fire Brigade, it said. The company is in the process of ascertaining the actual loss caused by the fire and has informed the insurance company.
PAPERPROD PNJZY 532461 PNB 509820

33
Closing Bell: Sensex down over 200 pts, Nifty ends below 10,650; banks drag

2018-06-04 moneycontrol
RBI Policy Expectations: India Ratings believes the Reserve Bank of India’s Monetary Policy Committee (MPC) will keep the policy rate unchanged in its upcoming review.
500325 500820 RELIANCE 532714 532978 BHRQY ASIANPAINT 532343 500470 PAPERPROD RIGD HDFCBANK 500570 BHARTIARTL KEC TATAMOTORS 509488 509820 RLNIY TVSMOTOR GRAPHITE KMBKY IBN 532454 ICICIBANK BAJAJFINSV TTST TATASTEEL TATLY HDB 532174 500180 KOTAKBANK 534809 500247 PCJEWELLER TTM

25
Market Live: Nifty extends losses, Sensex falls 200 pts; Nifty Bank sheds 400 pts

2018-06-04 moneycontrol
DHFL raises nearly Rs 11,000 crore: Housing financier DHFL has raised over Rs 10,944 crore through public issue of bonds which had open for subscription in May.
500325 500820 RELIANCE 532978 BHRQY ASIANPAINT CADILAHC 532321 PAPERPROD RIGD HDFCBANK 500570 BHARTIARTL TATAMOTORS 509820 RLNIY KMBKY IBN CDLYY 532454 ICICIBANK BAJAJFINSV HDB 532174 500180 KOTAKBANK 500247 TTM

32
Market Live: Sensex slips 100 pts, Nifty Bank dips 250 pts; advance:decline ratio 3:1

2018-06-04 moneycontrol
Earnings in the final quarter of FY18 were marked by sustained traction and the prospect of capex in consumption-facing businesses, infrastructure spending by the government, and strong growth in commodity-driven companies and digital-ready information technology players.
500325 RELIANCE 533278 CADILAHC 532321 PAPERPROD 532187 ANANTRAJ RIGD 526521 HDFCBANK HEROMOTOCO BJJQY SANGHIIND 500570 TATAMOTORS CLNDY 509820 RLNIY 500034 515055 INDUSINDBK IBN CANFINHOME 511196 CDLYY 500182 ICICIBANK BAJFINANCE HDB 532174 500180 HRTQY COALINDIA TTM

0
Huhtamaki PPL Limited - Updates

2018-06-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

0
Huhtamaki PPL Limited - Updates

2018-06-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

0
Huhtamaki PPL Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

0
Huhtamaki PPL Limited - Shareholders meeting

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

0
Huhtamaki PPL Limited - Shareholders meeting

2018-05-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

0
Huhtamaki PPL Limited - Financial Result Updates

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

1
ABB, Mahindra Holidays results on Tuesday

2018-05-07 thehindubusinessline
Over two dozen companies including ABB India, AB Capital, Automotive Axles, Blue Dart Express, De Nora, Godrej Consumer, GTL Infra, HEG, Hindustan Composites, India Nippon, Jubilant Foodworks, Kajaria Ceramics, Huhtamaki PPL, Mahindra Holidays, Phoenix Mills, SKF India, Sun Pharma Advanced, Sadbhav Infrastructure, Sanofi India, Sintex Industries, Whirlpool of India and Vesuvius will declare their fourth quarter and annual results for the period ended March 2018 on Tuesday.
SANOFI ABB PHOENIXLTD KAJARIACER 533155 JUBLFOOD 509635 505010 PAPERPROD AUTOAXLES SINTEX 500002 JBLWY SKFINDIA 502742 500233 500674 ABBDY HINDCOMPOS 503100 500472 526612 BLUEDART 509820

0
Huhtamaki PPL Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PAPERPROD 509820

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...